Case File
efta-efta00748322DOJ Data Set 9OtherFrom: Jeffrey Epstein <[email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00748322
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <[email protected]>
To: Michael A Taormina
Subject: Re: today's deals
Date: Thu, 15 Apr 2010 15:53:22 +0000
we need to be careful that we receive larger allocations to the deals that are overpriced. and open down. hold till
next week
On Thu, Apr 15, 2010 at 11:05 AM, Michael A Taormina <
> wrote:
Jeff,
There is one remaining deal from this morning on which we wanted to provide an update. We received 22,000 MAC. It
priced at 41. It is trading down around 40.63. After speaking with some of our traders, we're inclined to hold on to it, but
let us know if you prefer to sell.
Let me know if you have any questions,
Michael
Michael A. Taormina, CFA
J.P. Morgan I Global Investment Opportunities Group
40 West 57th Street, Floor 33
New York, NY 10019
T: 212-622-2701
F: 212-310-0108
IRS Circular 230 Disclosure:
.111Morgan Chase & Co. and its affiliates do not provide tax advice. Accordingly, any discussion of U.S. tax
matters contained herein (including any attachments) is not intended or written to be used, and cannot be used, in connection with the
promotion, marketing or recommendation by anyone unaffiliated with .1PMorgan Chase & Co. of any of the matters addressed herein
or for the purpose of avoiding U.S. tax-related penalties.
This communication is for informational purposes only. It is not intended as an offer or solicitation for the
purchase or sale of any financial instrument or as an official confirmation of any transaction. All market prices,
data and other information are not warranted as to completeness or accuracy and are subject to change without
notice. Any comments or statements made herein do not necessarily reflect those of JPMorgan Chase & Co.,
its subsidiaries and affiliates. This transmission may contain information that is privileged, confidential,
EFTA00748322
legally privileged, and/or exempt from disclosure under applicable law. If you are not the intended recipient,
you are hereby notified that any disclosure, copying, distribution, or use of the information contained herein
(including any reliance thereon) is STRICTLY PROHIBITED. Although this transmission and any attachments
are believed to be free of any virus or other defect that might affect any computer system into which it is
received and opened, it is the responsibility of the recipient to ensure that it is virus free and no responsibility
is accepted by JPMorgan Chase & Co., its subsidiaries and affiliates, as applicable, for any loss or damage
arising in any way from its use. If you received this transmission in error, please immediately contact the
sender and destroy the material in its entirety, whether in electronic or hard copy format. Thank you. Please
refer to http://www.jpmorgan.com/pages/disclosures for disclosures relating to European legal entities.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments.
EFTA00748323
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Phone
212-310-0108Phone
212-622-2701URL
http://www.jpmorgan.com/pages/disclosuresRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.